We aim to systematically review and meta-analyze the effectiveness and safety of
psychedelics [psilocybin, ayahuasca (active component DMT), LSD and MDMA] in treating …

After a long hiatus, psychiatry is undergoing a resurgence of interest in psychedelic drugs as
therapy for a wide range of mental health disorders Accumulating clinical evidence suggests …

Interest in and availability of psychedelics for therapeutic purposes has increased in recent
decades. In a large, anonymous, online survey, we investigated patterns of communication …

Introduction There is substantial public interest in psychedelics as potential treatments for
psychiatric conditions. However, most psychedelics are criminalized under federal law in the …

Background: Psilocybin, a classic hallucinogen, may eventually be approved by the United
States Food and Drug Administration for treatment-resistant depression. However, we are …

Substance use disorders (SUDs) have an enormous impact on public health. With classic
psychedelic-assisted therapies showing initial promise in treating multiple SUDs, it is …

Abstract Background and Objectives In recent years, there has been accelerating scientific
and public interest in the use of psychedelics to treat mental health disorders. Our study's …

Background and aims Because psychedelic-assisted therapy (PAT) is likely to be provided
by interdisciplinary professional teams comprised of social workers, psychologists, and …

Although psychedelic and hallucinogenic substances have gained popularity for therapeutic
use, their dermatologic adverse effects are poorly characterized. This review characterizes …

Background and aims Scientific interest in the therapeutic potential of psychedelics has
been experiencing significant growth. Understanding the perceptions of psychedelic …